Loading…
Laurus Labs (LAURUSLABS)₹2,454+3.54%Pharmaceuticals
At the end of the Sep 2026 quarter, Laurus Labs' shareholders were: promoters 27.48%, FIIs 30.82%, DIIs 11.88%, public 29.82%. Promoter holding is unchanged on the quarter. FII holding is up 4.67 percentage points from 26.15% a year earlier. 2.70% of promoter shares were pledged. It had 3,11,873 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 27.19% | 27.19% | 27.19% | 27.19% | 27.63% | 27.63% | 27.61% | 27.61% | 27.50% | 27.50% | 27.48% | 27.48% |
| FIIs | 25.37% | 25.96% | 25.65% | 26.06% | 25.54% | 25.49% | 25.68% | 26.15% | 26.50% | 25.80% | 27.98% | 30.82% |
| DIIs | 11.15% | 11.80% | 13.58% | 13.07% | 12.76% | 11.80% | 11.96% | 11.74% | 12.44% | 13.98% | 13.75% | 11.88% |
| Public | 36.29% | 35.05% | 33.58% | 33.68% | 34.07% | 35.08% | 34.75% | 34.50% | 33.56% | 32.72% | 30.79% | 29.82% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 2.70% |
| Number of shareholders | 3,82,856 | 3,56,808 | 3,24,039 | 3,09,044 | 2,92,196 | 2,92,887 | 2,80,206 | 2,83,660 | 2,80,739 | 2,92,263 | 2,91,635 | 3,11,873 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| M/s. NSN Holdings (Represented by its Managing Partner, Dr. Satyanarayana Chava) | Promoter | 22.93% | −0.01 |
| Mirae Asset Nifty India Manufacturing Etf | DII | 4.00% | New |
| New World Fund Inc | FII | 3.54% | −0.76 |
| Anukar Projects Private Limited | Public | 3.23% | 0.00 |
| Chunduru Venkata Lakshmana Rao | Promoter | 2.67% | 0.00 |
| Smallcap World Fund, Inc | FII | 2.27% | −0.52 |
| Barclays Wealth Trustees India Private Limited | Public | 1.56% | 0.00 |
| Akash Bhanshali | Public | 1.31% | 0.00 |
| M/s. Leven Holdings (Represented by its Managing Partner, Mr. Venkata Ravi Kumar Vantaram) | Promoter | 1.14% | 0.00 |
| Sbi Life Insurance Co. Ltd | DII | 1.06% | New |
| Vanguard Total International Stock Index Fund - 2 | FII | 0.99% | New |
| Satyanarayana Chava | Promoter | 0.29% | 0.00 |
| Venkata Ravi Kumar Vantaram | Promoter | 0.19% | 0.00 |
| Hymavathi Vantaram | Promoter | 0.04% | 0.00 |
| Krishnaveni Vasireddi | Promoter | 0.04% | 0.00 |
| Narasimha Rao Suryadevara | Promoter | 0.03% | 0.00 |
| Rama Suryadevara | Promoter | 0.03% | 0.00 |
| Chava Narasimha Rao | Promoter | 0.02% | 0.00 |
| Nagamani Thokala | Promoter | 0.02% | 0.00 |
| Sekhar Babu Chunduru | Promoter | 0.02% | 0.00 |
| Chandrakanth Chereddi | Promoter | 0.01% | 0.00 |
| Rishi Tej Chava | Promoter | 0.01% | New |
| Satya Tej Chava | Promoter | 0.01% | New |
| Mirae Asset Large & Midcap Fund | DII | Exited | — |
| Kotak Funds - India Midcap Fund | FII | Exited | — |
Promoters held 27.48% of Laurus Labs at the end of the Sep 2026 quarter, down 0.13 percentage points from 27.61% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 30.82% (up 2.84 percentage points from 27.98% a quarter earlier) and domestic institutions (DIIs) held 11.88% (down 1.87 percentage points from 13.75% a quarter earlier).
Yes. 2.70% of promoter shares were pledged at the end of the Sep 2026 quarter.
Laurus Labs had 3,11,873 shareholders at the end of the Sep 2026 quarter, against 2,83,660 a year earlier.
Mirae Asset Nifty India Manufacturing Etf (DII) held 4.00% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.